- Home
- LSBK vs VTGN Comparison
LSBK vs VTGN Comparison
Compare LSBK & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSBK
- VTGN
- Stock Information
- Founded
- LSBK 1891
- VTGN 1998
- Country
- LSBK United States
- VTGN United States
- Employees
- LSBK N/A
- VTGN N/A
- Industry
- LSBK Savings Institutions
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- LSBK Finance
- VTGN Health Care
- Exchange
- LSBK Nasdaq
- VTGN Nasdaq
- Market Cap
- LSBK 76.9M
- VTGN 82.0M
- IPO Year
- LSBK 2006
- VTGN N/A
- Fundamental
- Price
- LSBK $13.51
- VTGN $2.63
- Analyst Decision
- LSBK
- VTGN Strong Buy
- Analyst Count
- LSBK 0
- VTGN 1
- Target Price
- LSBK N/A
- VTGN $15.00
- AVG Volume (30 Days)
- LSBK 1.2K
- VTGN 261.1K
- Earning Date
- LSBK 10-23-2024
- VTGN 11-07-2024
- Dividend Yield
- LSBK 5.33%
- VTGN N/A
- EPS Growth
- LSBK N/A
- VTGN N/A
- EPS
- LSBK 0.75
- VTGN N/A
- Revenue
- LSBK $25,338,000.00
- VTGN $876,000.00
- Revenue This Year
- LSBK N/A
- VTGN N/A
- Revenue Next Year
- LSBK N/A
- VTGN N/A
- P/E Ratio
- LSBK $18.10
- VTGN N/A
- Revenue Growth
- LSBK N/A
- VTGN 8.16
- 52 Week Low
- LSBK $10.12
- VTGN $2.58
- 52 Week High
- LSBK $14.21
- VTGN $5.86
- Technical
- Relative Strength Index (RSI)
- LSBK 49.26
- VTGN 27.78
- Support Level
- LSBK $13.38
- VTGN $3.06
- Resistance Level
- LSBK $13.90
- VTGN $3.24
- Average True Range (ATR)
- LSBK 0.15
- VTGN 0.14
- MACD
- LSBK -0.02
- VTGN -0.05
- Stochastic Oscillator
- LSBK 37.14
- VTGN 7.35
About LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.